March 3, 2026
1 min read

Adia Nutrition Announces Submission of Final Revised Protocol for Lower Back Pain Study with AdiaVita

Winter Park, Florida–(Newsfile Corp. – March 3, 2026) – Adia Nutrition Inc. (OTCQB: ADIA), a company focused on regenerative medicine and therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its final revised protocol to the Institutional Review Board (IRB) for the lower back pain clinical study.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/286105_img_8679_1.jpgFollowing the initial…

Leave a Reply

Your email address will not be published.

Previous Story

Nearly 20 States Scale Back HIV Medication Programs MedNews

Next Story

AI Therapist? It Falls Short, a New Study Warns MedNews

Previous Story

Nearly 20 States Scale Back HIV Medication Programs MedNews

Next Story

AI Therapist? It Falls Short, a New Study Warns MedNews

Latest from Blog

Go toTop